Cell News and Research

RSS

Scientists design 'fishing' technique to show health benefits of foods

New research suggests that a compound abundant in the Mediterranean diet takes away cancer cells' "superpower" to escape death.

21 May 2013

Researchers pinpoint catalytic trigger for onset of Alzheimer's disease

Researchers have pinpointed a catalytic trigger for the onset of Alzheimer's disease - when the fundamental structure of a protein molecule changes to cause a chain reaction that leads to the death of neurons in the brain.

21 May 2013

Researchers examine how BRD4 contributes to sustained presence of NF-kappa B in cancer cells

In a new study described in the journal Oncogene, researchers reveal how a key player in cell growth, immunity and the inflammatory response can be transformed into a primary contributor to tumor growth.

20 May 2013

Cell Therapeutics announces issuance of final benefit assessment report for PIXUVRI

Cell Therapeutics, Inc. today reported that Germany's Federal Joint Committee has issued its final benefit assessment report for PIXUVRI (pixantrone), which is indicated as a monotherapy for the treatment of adult patients with aggressive B-cell non-Hodgkin lymphoma (NHL) who have failed two or three prior lines of therapy.

20 May 2013

AGA Research Foundation announces recipients of 2013 Student Research Fellowship Award

The American Gastroenterological Association Research Foundation has announced the 2013 Student Research Fellowship Award recipients. The awards are intended to stimulate interest in research careers in digestive diseases among high school, undergraduate, graduate and medical school students.

20 May 2013

New Kaiser Permanente study shows effectiveness of whole-cell pertussis vaccines

Whole-cell pertussis vaccines were more effective at protecting against pertussis than acellular pertussis vaccines during a large recent outbreak, according to a new Kaiser Permanente study published in Pediatrics.

20 May 2013

Measuring genetic diversity within tumor predicts outcomes of patients with head and neck cancer

A new measure of the heterogeneity - the variety of genetic mutations - of cells within a tumor appears to predict treatment outcomes of patients with the most common type of head and neck cancer.

20 May 2013

AGA Research Foundation announces 2013 research scholars

The American Gastroenterological Association Research Foundation is pleased to announce its 2013 research scholars. This year's honorees are outstanding young gastroenterologists working toward independent careers in gastroenterology, hepatology or related areas, and with this award, their research time will be protected.

20 May 2013

New computational method may help track tumor progression, risk of relapse

In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual cells. These technologies have led to new challenges, however, as scientists now struggle with how to make sense of the resulting trove of data. Now a solution may be at hand.

20 May 2013

Students receive Addiction Science Award at 2013 Intel International Science and Engineering Fair

An exploration of electronic "screen time" and sleep on mood, memory and learning was given the top Addiction Science Award at the 2013 Intel International Science and Engineering Fair - the world's largest science competition for high school students.

20 May 2013

Boehringer Ingelheim to highlight respiratory research work at ATS 2013

Boehringer Ingelheim will contribute to advancing the scientific discussion in respiratory disease at the American Thoracic Society International Conference in Philadelphia, PA, May 17 – 22.

20 May 2013

Understanding the role of dsRNA in antiviral host defense systems

Animals, insects, and plants use a variety of sensing mechanisms to detect invading pathogens such as viruses. One complex and effective antiviral defense system they share is based on recognition of double-stranded RNA, often produced when a virus invades a host cell.

20 May 2013

App could save lives by speeding treatment for heart attack

An experimental, inexpensive iPhone application transmitted diagnostic heart images faster and more reliably than emailing photo images, according to a research study presented at the American Heart Association's Quality of Care and Outcomes Research Scientific Sessions 2013.

18 May 2013

Innovative X-ray method advances new treatments for genetic diseases

An international team of scientists using a new X-ray method recorded the internal structure and cell movement inside a living frog embryo in greater detail than ever before.

18 May 2013

RUCDR Infinite Biologics creates new Genomics Technology Center

RUCDR Infinite Biologics, the world's largest university-based biorepository, has completed an $11.8 million renovation project to create a new Genomics Technology Center, comprising 12,500 square feet of laboratory, office, and storage space on the Busch Campus of Rutgers, The State University of New Jersey.

18 May 2013

Transcranial random noise stimulation allows the brain to work more efficiently, say researchers

In the future, if you want to improve your ability to manipulate numbers in your head, you might just plug yourself in. So say researchers who report in the Cell Press journal Current Biology on May 16 on studies of a harmless form of brain stimulation applied to an area known to be important for math ability.

18 May 2013

EHRA EUROPACE 2013 to feature late breaking clinical trials

Attendees will have the opportunity to hear the results of cutting edge studies, and to learn about the new Guidelines which are likely to have a tremendous impact on the European health care system.

18 May 2013

Alnylam reports pre-clinical data from ALN-AS1 program for treatment of AIP

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented key pre-clinical proof-of-concept data from its RNAi therapeutic program targeting aminolevulinate synthase-1 (ALAS-1) for the treatment of porphyria including acute intermittent porphyria.

18 May 2013

Research findings could lead to new therapies for stroke and other brain diseases

Scientists investigating the interaction of a group of proteins in the brain responsible for protecting nerve cells from damage have identified a new target that could increase cell survival.

18 May 2013

Thioridazine works by weakening staphylococcal cell wall, new study reveals

In 2008 researchers from the University of Southern Denmark showed that the drug thioridazine, which has previously been used to treat schizophrenia, is also a powerful weapon against antibiotic-resistant bacteria such as staphylococci (Staphylococcus aureus).

18 May 2013

Cell News and Research

Scientists design 'fishing' technique to show health benefits of foods

Researchers pinpoint catalytic trigger for onset of Alzheimer's disease

Researchers examine how BRD4 contributes to sustained presence of NF-kappa B in cancer cells

Cell Therapeutics announces issuance of final benefit assessment report for PIXUVRI

AGA Research Foundation announces recipients of 2013 Student Research Fellowship Award

New Kaiser Permanente study shows effectiveness of whole-cell pertussis vaccines

Measuring genetic diversity within tumor predicts outcomes of patients with head and neck cancer

AGA Research Foundation announces 2013 research scholars

New computational method may help track tumor progression, risk of relapse

Students receive Addiction Science Award at 2013 Intel International Science and Engineering Fair

Boehringer Ingelheim to highlight respiratory research work at ATS 2013

Understanding the role of dsRNA in antiviral host defense systems

App could save lives by speeding treatment for heart attack

Innovative X-ray method advances new treatments for genetic diseases

RUCDR Infinite Biologics creates new Genomics Technology Center

Transcranial random noise stimulation allows the brain to work more efficiently, say researchers

EHRA EUROPACE 2013 to feature late breaking clinical trials

Alnylam reports pre-clinical data from ALN-AS1 program for treatment of AIP

Research findings could lead to new therapies for stroke and other brain diseases

Thioridazine works by weakening staphylococcal cell wall, new study reveals

How to optimize your cell line development eBook

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest Life Science News